BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2011

Aug 2, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2011-07-29

Reporting Person: Davis George Eric (SVP, General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-07-29	Common Stock	M	3800	$11.74	Acquired	43451	Direct
2011-07-29	Common Stock	S	3800	$31.00	Disposed	39651	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-07-29	Stock Option (Right to Buy)	$11.74	M	3800	Disposed	2016-01-05	Common Stock (3800)	Direct

Footnotes

F1: Transaction made pursuant to a Rule 10b5-1 Trading plan executed on March 7, 2011.

F2: Original option grant 6/48ths on July 6, 2006 and 1/48th on the 6th day of every month thereafter.